Avita Medical | 1811094D - 時価総額

株価
1.24
毎日の変更
0.01 0.81%
毎月
14.29%
毎年
-60.26%
Q2 予測
1.22


金融部門
株価
AUD
資産
AUD 56.39M
現金と同等
AUD 10.24M
売上原価
AUD 3.3M
流動資産
AUD 35.49M
流動負債
AUD 62.68M
負債
AUD 46.05M
EBIT
AUD -10.39M
EBITDA
AUD -9.69M
従業員
AUD 87
株当たりのEPS利益
AUD -0.38
自己資本および準備金
AUD -16.65M
売上総利益
AUD 14.31M
債務の支払利息
AUD 1.25M
借入資本
AUD 42.25M
時価総額
AUD 161.96M
当期純利益
AUD -11.62M
営業経費
AUD 28.02M
営業利益
AUD -10.41M
税引前利益
AUD -11.64M
販売収入
AUD 17.62M
販売および管理費
AUD 19.03M
株式
AUD 6.93M
貿易債権者
AUD 8.96M
貿易債務者
AUD 9.11M


時価総額 変化する 日付
Clinuvel Pharmaceuticals AUD 625.5M 105.22M 2025-12
Cochlear AUD 17.05B 2.6B 2025-12
CSL USD 55.89B 20.42B 2025-12
Cspc Pharmaceutical CNY 87.29B 19.74B 2025-12
Deva Holding AS TRY 17.54B 7.76B 2023-09
Dianthus Therapeutics USD 1.78B 215M 2025-12
Divis Laboratories Ltd INR 1.7T 186.62B 2025-12
Kangmei Pharma CNY 27.93B 1.73B 2025-09
Knight Therapeutics CAD 600.53M 14.56M 2025-12
Laboratorios Farma EUR 4.17B 917.16M 2026-03
Malin Corporation EUR 142.92M 19.65M 2026-02
Mayne Pharma AUD 252.67M 153.55M 2025-12
Medical Developments International AUD 62.53M 563.29K 2025-12
Nanosonics AUD 1.2B 25.43M 2025-12
Neuren Pharmaceuticals AUD 2.36B 606.56M 2025-12
Organigram Holdings CAD 312.16M 66.64M 2025-12
Ovoca Bio EUR 6.12M 4.93M 2026-04
Pacific Edge NZD 194.21M 87.84M 2025-12
Paradigm Biopharmaceuticals AUD 145.7M 26.92M 2025-12
Pharma Mar EUR 1.71B 360.22M 2026-04
Polynovo AUD 849.74M 24.18M 2025-12
PYC Therapeutics AUD 965.3M 209.97M 2025-12
Qiagen NV USD 6.8B 1.47B 2026-04
Ramsay Health Care AUD 7.93B 537.83M 2025-12
ResMed USD 52.52B 12.57B 2025-12
Sartorius EUR 7.48B 6.76B 2026-04
Telix Pharmaceuticals AUD 5.07B 5.81B 2025-12
Zealand Pharma A/S 33.35B 0 2026-04
Zz Pientze Pharmaceu CNY 84.65B 34.08B 2026-04